Login / Signup

Joint association of patients' sex and PD-L1 expression with overall survival benefits and tumor-immune microenvironment in immune checkpoint inhibitors for cancers.

Anlin LiYongjian ChenWenda ZhangHaitao ZhongQiyun OuYang GuJunqing XiaDagui LinTuping FuRuixin LiuHai HuYunfang YuHe-Rui Yao
Published in: Clinical and translational medicine (2020)
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • stem cells
  • prognostic factors
  • patient reported outcomes
  • free survival